Precision treatment in advanced hepatocellular carcinoma
X Yang, C Yang, S Zhang, H Geng, AX Zhu… - Cancer Cell, 2024 - cell.com
The past decade has witnessed significant advances in the systemic treatment of advanced
hepatocellular carcinoma (HCC). Nevertheless, the newly developed treatment strategies …
hepatocellular carcinoma (HCC). Nevertheless, the newly developed treatment strategies …
[HTML][HTML] Clinical significance of genomic sequencing of circulating tumour cells (CTCs) in cancer
A Auwal, MM Hossain, TUH Pronoy, KM Rashel… - The Journal of Liquid …, 2024 - Elsevier
Circulating tumour cell (CTC), a rare subpopulations of tumour cells, plays a significant role
in cancer metastasis and recurrence. The current review focuses on information of CTCs …
in cancer metastasis and recurrence. The current review focuses on information of CTCs …
Integrating anoikis and ErbB signaling insights with machine learning and single-cell analysis for predicting prognosis and immune-targeted therapy outcomes in …
H Fang, X Chen, Y Zhong, S Wu, Q Ke… - Frontiers in …, 2024 - frontiersin.org
Background Hepatocellular carcinoma (HCC) poses a significant global health challenge
due to its poor prognosis and limited therapeutic modalities. Anoikis and ErbB signaling …
due to its poor prognosis and limited therapeutic modalities. Anoikis and ErbB signaling …
[HTML][HTML] Liver resection and transplantation in the era of checkpoint inhibitors
P Tabrizian, R Marino, PKH Chow - JHEP Reports, 2024 - Elsevier
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for
advanced hepatocellular carcinoma (HCC). The combination of Atezolizumab and …
advanced hepatocellular carcinoma (HCC). The combination of Atezolizumab and …
Deep learning model based on contrast-enhanced ultrasound for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma
W Xu, H Zhang, R Zhang, X Zhong, X Li, W Zhou… - European …, 2024 - Springer
Objectives To establish and validate a non-invasive deep learning (DL) model based on
contrast-enhanced ultrasound (CEUS) to predict vessels encapsulating tumor clusters …
contrast-enhanced ultrasound (CEUS) to predict vessels encapsulating tumor clusters …
[HTML][HTML] Identification and evaluation of plasma exosome RNA biomarkers for non-invasive diagnosis of hepatocellular carcinoma using RNA-seq
H Huang, M Zhang, H Lu, Y Chen, W Sun, J Zhu… - BMC …, 2024 - pmc.ncbi.nlm.nih.gov
Background Non-invasive diagnostic methods, including medical imaging techniques and
blood biomarkers such as alpha-fetoprotein (AFP), have been crucial in detecting …
blood biomarkers such as alpha-fetoprotein (AFP), have been crucial in detecting …
[HTML][HTML] 循环肿瘤细胞检测在临床癌症的应用进展
张宁伟， 任宾 - Advances in Clinical Medicine, 2023 - hanspub.org
随着精准医学的发展, 液体活检技术开始在临床上广泛应用. 循环肿瘤细胞(CTC)
是从原发性肿瘤脱离进入外周血液循环的肿瘤细胞, 经过一系列迁移, 黏附和聚集后形成新的 …
是从原发性肿瘤脱离进入外周血液循环的肿瘤细胞, 经过一系列迁移, 黏附和聚集后形成新的 …
[HTML][HTML] A Revolutionary Era in Advancing Precision Immuno-oncology; Role of Circulating Tumor Cells
Despite a substantial progress in the development of strategies against cancer, cancer still
remains a major global health issue due to a high recurrence rate, and severe side effects …
remains a major global health issue due to a high recurrence rate, and severe side effects …
[HTML][HTML] 液体活检技术在肝癌诊治中的现状和发展
李林翰， 张大志 - Advances in Clinical Medicine, 2024 - hanspub.org
肝癌多是在慢性肝病基础上产生的一种肿瘤. 由于其早期诊断率低, 多数患者初诊时已经处于中
晚期. 随着基因组学技术的发展, 液体活检在肝癌中的应用已被研究得较多. 本文主要介绍了循环 …
晚期. 随着基因组学技术的发展, 液体活检在肝癌中的应用已被研究得较多. 本文主要介绍了循环 …